burn-out, bipolaire, depressieve, psychotische en posttraumatische stressstoornissen anxiety anxiety disorders
Conditions
Interventions
VRelax is a VR self-management tool aimed at reducing stress and sleep
disturbances that can be used as a self-help intervention at home without the
guidance of a professional. Patients wear a stand
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: - Currently receiving treatment for burn-out which is defined according to the Dutch GP *Overspanning en burn-out* guideline, and includes the International Classification of Primary Care (ICPC) categories of *surmenage* (P78) and *burn-out*(Z29.01), or diagnosed with anxiety disorder, bipolar disorder, depressive disorder, psychotic disorder or post-traumatic stress disorder according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM), 5th edition. - Complaints of stress and/or sleep disturbances as reported by patient or therapist - Age > 18 .
Exclusion criteria
Exclusion criteria: - DSM-5 diagnosis of substance use disorder. - Photosensitive epilepsy with seizure in the past year or organic brain damage. - Intellectual disability (estimated IQ
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is level of symptoms measured with the Dutch version of the Symptom Checklist-90-Revised (SCL-90-R). Participants will complete the SCL-90-R at baseline (T0) and after six weeks of using VRelax or controlled use of relaxation exercises (T1). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes are psyciatric symptoms (measured with BAI, PSYRATS, HRSD, BAT, MDQ, and PCL-5) psychosocial functioning and medication use (measured with WHO-DAS II), functioning and recovering (measured with MANSA and Recovery Assessment Scale), substance use (measured with ASSIST), perceived stress (measured with perceived stress scale), sleep (measured with PSQI), cost-effectiveness (measured with TiC-P and EQ-5D-5L) and physical health (measured with SF-36). Three questions are asked about preferences for VRelax or relaxation exercises, personal experiences that participants bring after using VRelax or relaxation exercises, and activities undertaken regarding stress and stress management. Level of calmness and relaxation will be measured daily with Visual Analogue Scales. Physiological parameters of stress and sleep will be measured during the intervention period using ambulatory measurements. In addition, a daily sleep questionnaire is administered to gain a better understanding of sleep. Physiological parameters of stress will also be measured in a lab setting at the UMCG. Physiological markers of comorbid somatic diseases are measured by physical examination (including weight, blood pressure, and blood sampling). | — |
Countries
Netherlands
Outcome results
None listed